MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkx095

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2017

Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.

Ntamatungiro Alex J, Muri Lukas, Glass Tracy R, Erb Stefan, Battegay Manuel, Furrer Hansjakob, Hatz Christoph, Tanner Marcel, Felger Ingrid, Klimkait Thomas, Letang Emilio, KIULARCO Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES

To assess viral suppression rates, to assess prevalence of acquired HIV drug resistance and to characterize the spectrum of HIV-1 drug resistance mutations (HIV-DRM) in HIV-1-infected patients in a rural Tanzanian HIV cohort.

METHODS

This was a cross-sectional study nested within the Kilombero and Ulanga Antiretroviral Cohort. Virological failure was defined as HIV-1 RNA ≥50 copies/mL. Risk factors associated with virological failure and with the development of HIV-DRM were assessed using logistic regression.

RESULTS

This study included 304 participants with a median time on ART of 3.5 years (IQR = 1.7-5.3 years); 91% were on an NNRTI-based regimen and 9% were on a boosted PI-based regimen. Viral suppression was observed in 277/304 patients (91%). Of the remaining 27 patients, 21 were successfully genotyped and 17/21 (81%) harboured ≥1 clinically relevant HIV-DRM. Of these, 13/17 (76.5%) had HIV-1 plasma viral loads of >1000 copies/mL. CD4 cell count <200 cells/mm(3) at the time of recruitment was independently associated with a close to 8-fold increased odds of virological failure [adjusted OR (aOR) = 7.71, 95% CI = 2.86-20.78, P  <   0.001] and with a >8-fold increased odds of developing HIV-DRM (aOR = 8.46, 95% CI = 2.48-28.93, P  =   0.001).

CONCLUSIONS

High levels of viral suppression can be achieved in rural sub-Saharan Africa when treatment and care programmes are well managed. In the absence of routine HIV sequencing, the WHO-recommended threshold of 1000 viral RNA copies/mL largely discriminates virological failure secondary to HIV-DRM.

Для цитирования: Ntamatungiro Alex J, Muri Lukas, Glass Tracy R, Erb Stefan, Battegay Manuel, Furrer Hansjakob, Hatz Christoph, Tanner Marcel, Felger Ingrid, Klimkait Thomas, Letang Emilio, KIULARCO Study Group. Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression.. The Journal of antimicrobial chemotherapy. 2017. DOI: 10.1093/jac/dkx095.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.